First-of-its-kind mRNA production lab in Asia paves way for pandemic preparedness

Called the NATi mRNA BioFoundry, the laboratory can quickly produce materials for pre-clinical or animal studies for vaccines to respond to future pandemics, or drugs to combat cancers and other diseases.Read More